Principal Investigator
Overview
Start/End Dates
Locations
Lions Gate Hospital
Name/Title
Valla Sahraei, Clinical Trials Coordinator
Phone
Email Address
Purpose of Study
The purpose of this study is to assess if the study drug, camizestrant, improves outcomes compared to standard adjuvant endocrine therapy for patients with ER+/HER2- early breast cancer with intermediate-high or high risk for disease recurrence who completed definitive locoregional therapy (with or without chemotherapy).
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
Start/End Dates
Locations
Lions Gate Hospital
Name/Title
Valla Sahraei, Clinical Trials Coordinator
Phone
Email Address
Purpose of Study
The purpose of this study is to assess if the study drug, camizestrant, improves outcomes compared to standard adjuvant endocrine therapy for patients with ER+/HER2- early breast cancer with intermediate-high or high risk for disease recurrence who completed definitive locoregional therapy (with or without chemotherapy).
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
